Skip to content

Rapid Micro Biosystems RPID Inventory write-downs

Inventory write-downs at other companies

Charles River Laboratories logo
Charles River LaboratoriesCRL
$1.49M-78.0%
Pacific Biosciences of California logo
Pacific Biosciences of CaliforniaPACB
$54K-99.3%
iRadimed logo
iRadimedIRMD
$15K+139%
Biodesix, Inc. logo
Biodesix, Inc.BDSX
$20K

Other financials

Income statement

See full
Revenue$8.0M+11.1%
Gross profit$371.0K-8.2%
Operating income-$13.9M-18.8%
Net income-$14.3M-26.7%
EPS (diluted)-$0.31-19.2%

Balance sheet

See full
Cash & equivalents$14.1M-26.8%
Total debt$23.8M+301%
Total equity$20.4M-68.9%
Total assets$62.4M-27.0%

Cash flow

See full
Operating cash flow-$15.1M-66.1%
CapEx$394.0K+23.5%
Free cash flow-$15.5M-64.7%

Valuation

See full
Market cap$86.19M-43.8%
Enterprise value$95.86M-31.7%
P/S2.5×-2.6×

Profitability

See full
Operating margin-144.2%-12.7pp
Net margin-145.8%-5.0pp
FCF margin-110.5%-14.9pp

Returns & leverage

See full
Return on equity-116.7%-620pp
Debt / equity1.2×+1.1×
Current ratio2.6×-2.0×

Where this comes from

Reported directly by Rapid Micro Biosystems in its filing.

Tagged under the XBRL concept us-gaap:InventoryWriteDown.

The official record: Rapid Micro Biosystems’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rapid Micro Biosystems's inventory write-downs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rapid Micro Biosystems's inventory write-downs?
Rapid Micro Biosystems (RPID) reported inventory write-downs of $0 in Q1 2026.
How has Rapid Micro Biosystems's inventory write-downs changed year-over-year?
Rapid Micro Biosystems's inventory write-downs decreased by 100.0% year-over-year, from $235K to $0.
What does inventory write-downs mean?
This reflects the adjustment to the carrying value of inventory due to obsolescence, damage, or market price declines below cost. It serves as a key indicator of inventory management efficiency and potential risks associated with product lifecycle or demand forecasting. High levels of write-downs may signal inefficiencies in supply chain management or declining product marketability.